PRKDC modification at either the ABCDE (S2612) or the PQR (S2056) phosphorylation clusters is highly sensitive to TNF-α treatment and is prevalent in sites of inflammation in human asthma and acute lung injury (pneumonia). Here, TNF is linked to pneumonia.